Search by Medical Condition

A B C D E F G H I J K L M N O P Q R S T U V W X Y Z

Clinical Trials for Anxiety Disorders

• A New Intervention to Improve Function in Veterans With Anxiety and Depression
• The Efficacy of Lavender and Chamomile Essential Oils Inhalation in Management of Dental Anxiety and Pain in Children Undergoing Local Anesthesia Administration and Primary Tooth Extraction
• Cannabidiol Effects on Fear Extinction in Social Phobia
• Comparing the Effect of Melatonin, Diazepam, and Placebo on Decreasing the Level of Anxiety Preoperatively
• Sertraline vs. Placebo in the Treatment of Anxiety in Children and AdoLescents With NeurodevelopMental Disorders
• Effect of Esketamine on Reducing Postoperative Anxiety and Depression in Adolescent Patients
• "Pain and Emotional Changes on Relationships Between Anxiety and Olfaction"
• Concentration-QT Study of Paroxetine in Healthy Adults
• A Study to Evaluate the Pharmacokinetics, Safety, and Tolerability of ABBV-932 in Healthy Adult Participants, Participants With Generalized Anxiety Disorder (GAD) and Participants With Bipolar Disorder (BPD)
• Processes and Circuitry Underlying Threat Sensitivity as a Treatment Target for Co-morbid Anxiety and Depression
• Effect of Aromatherapy on Preoperative Anxiety Level
• Cannabidiol to Reduce Anxiety Reactivity: A Randomized Controlled Trial in Social Anxiety Disorder
• Self-Administered Nitrous Oxide (SANO) During Transrectal Prostate Biopsy to Reduce Patient Anxiety and Pain
• Randomized Clinical Trial of Shugan Jieyu Capsule in Generalized Anxiety Disorder
• Nebulized Dexmedetomidine VS ODF Melatonin for Peri Operative Anxiety and Emergence Agitation in Pediatric Day Surgery
• ENCALM: A Study of ENX-102 as a Monotherapy Treatment in Patients With Generalized Anxiety Disorder
• Study to Assess Adverse Events and How ABBV-932 Oral Capsules Moves Through the Body of Healthy Adult Participants
• Influence of Oxycodone on Individuals Taking an SSRI
• Effect of SPG Block for Patients With Anxiety at Electronic Dance Music Festivals
• A Clinical Study That Will Meaure How Well SEP-363856 Works and How Safe it is in Adults With Generalized Anixety Disorder
• Virtual Reality Hypnosis in Total Knee Arthroplasty Under Spinal Anesthesia
• A Multicenter Randomized Controlled Study of Pulse Magnetotherapy Combined Medication in Anxiety Combined With Insomnia
• Neural Markers of Treatment Mechanisms and Prediction of Treatment Outcomes in Social Anxiety
• Comparison Between Oral Melatonin and Hydroxyzine in Pediatric Patients Undergoing Adenotonsillectomy
• Investigating the Effects of Cannabidiol on Social Anxiety Disorder
• Pain and Anxiety in Peripheral Venous Catheterization, Jet Lidocaine, Ice Application
• Effect of Different Doses of Dexmedetomidine on Cerebral Oxygen Saturation and Postoperative Anxiety in Elderly Patients
• Music vs Midazolam During Preop Nerve Block Placement - Part 2 Study On Anxiolytic Options Before Peripheral Nerve Blocks
• Efficacy and Safety of Tenoten in the Treatment of Children With Anxiety Disorders
• Cannabidiol (CBD) for the Treatment of Social Anxiety Disorder
• A Study of the Efficacy and Safety of Ranquilon Tablets in Patients With Anxiety in Neurasthenia and Adjustment Disorders
• Cannabidiol as a Treatment for Social Anxiety Disorder (R61)
• The Effect of Aromatherapy on Anxiety in Patients
• Intranasal Dexmedetomidine for Severe Dental Anxiety: a Randomized Trial
• Comparison of Pharmacological and Non-Pharmacological Interventions For Alleviating Preoperative Anxiety In Children
• Safety, Tolerability, and Efficacy of RLS103 in Subjects With Acute Anxiety Within Social Anxiety Disorder (SAD)
• A Dose-Finding Study of MM-120 for the Treatment of Anxiety Symptoms
• Cariprazine Versus Placebo for Social Anxiety Disorder
• Digital Interventions as an Add-on Tool in Generalized Anxiety Disorder Treatment
• Ketamine-Assisted PsychoTherapy ViAbility in Treating Cancer-related Emotional Distress
• Epidiolex® for Anxiety in Pediatric Epilepsy
• Cannabidiol Effects on Learning and Anxiety
• Pharmaco-Neuroimaging Studies of Approach/Avoidance Behaviors and Post-Mortem Studies: Study 1.1. (Pharmacological Manipulation)
• Melatonin Versus Hydroxizin for Pre Operative Anxiety in Elderly Patients With Hip Fracture
• A Phase 2 Study of BNC210 for the Acute Treatment of Social Anxiety Disorder
• Comparative Clinical Study Between Virtual Reality Hypnosis and Nitrous Oxide Inhalation for Dental Anxie
• Social Anxiety MDMA-Assisted Therapy Investigation
• Bryophyllum Pinnatum Treatment of Anxiety Related to Preterm Labour
• Feasibility Study of Oral Ketamine Versus Placebo for the Treatment of Anxiety in Patients With Pancreatic Cancer
• Pharmacological Effects of Pascoflair® on Brain Activity in Patients Suffering From Test Anxiety
• Open-label Safety Trial of PH94B in Social Anxiety Disorder (SAD)
• PH94B Nasal Spray for Anxiety Induced by a Public Speaking Challenge - 2
• Effects of Xiangshao Granules on Anxiety in Menopausal Women.
• Assessing the Efficacy of Micro-dosed Psilocybin on Reducing Anxiety & Depression Levels in Adults
• Research on Risk Factors and Interventions of Polycystic Ovary Syndrome Complicated With Depression and Anxiety
• Virtual Reality Exposure Therapy in the Intensive Treatment of Social Anxiety Disorder
• A Study To Assess Adverse Events and Change in Disease Activity With Oral Cariprazine When Added to Antidepressant Therapies (ADTs) Compared to Placebo in Adult Participants With Generalized Anxiety Disorder (GAD) Who Have Had an Inadequate Response
• Psilocybin Therapy for Depression and Anxiety in Parkinson's Disease
• Study of Dextromethorphan in OCD and Related Disorders
• Perceived Changes in Anxiety Symptom Burden During Treatment With Bryophyllum Pinnatum and Tolerability
• Buspirone Treatment of Anxiety in Williams Syndrome
• Evaluating the Effects of VQW-765 vs. Placebo in Performance Anxiety
• Fluoxetine vs CBT in Childhood Anxiety Disorders
• PH94B Nasal Spray for Anxiety Induced by a Public Speaking Challenge
• The Study of Hemp Oil CBD for Evaluation of Efficacy and Safety in Treatment of Pain, Anxiety and Insomnia Management
• Intranasal Remimazolam for Premedication in Pediatric Patient
• Pharmacogenetically-guided Escitalopram Treatment for Pediatric Anxiety: Aiming to Improve Safety and Efficacy (PrEcISE)
• Pre-emptive Pregabalin on Attenuating Maternal Anxiety And Stress Response To Intubation During Caesarean Section
• A Study to Assess the Efficacy and Safety of CD-008-0045 in Patients With Generalized Anxiety Disorder
• Partners in Caring for Anxious Youth
• A Novel Approach in Reducing Dental Pain and Anxiety of Pediatric Patient During Local Anesthesia.
• Cannabinoids for the Treatment of Anxiety Disorders: An 8-Week Pilot Study
• Efficacy of Electroencephalography (EEG) Neurofeedback (NF) for the Treatment of Anxiety Disorder
• Evaluating Stress Response and Anxiety Score in Paediatric Patients
• А Dose-finding Study to Assess the Efficacy and Safety of CD-008-0045 in Patients With Generalized Anxiety Disorder
• RCT of CBD for Anxiety in Advanced Breast Cancer
• Efficacy of Online CBT for GAD Compared to Pharmaceutical Interventions
• Affect of Duavive on Mood & Anxiety Symptoms
• Brain Hippocampal Volume Relationship With Anxious Symptoms in Major Depressive Patients
• Bioequivalence Study of Paroxetine and PAXIL Under Fasting Conditions in Healthy Mexican Participants
• A Clinical Trial of a Hemp-Derived Cannabidiol Product for Anxiety
• Treatment of Adults With Generalized Anxiety Disorder Using Glutamine
• Handheld-multimedia Versus Oral Midazolam in Pediatric on Perioperative Anxiety
• Cannabidiol for Anxiety
• Trial With the Treatment of Sertraline in Youth With Generalized, Separation and/or Social Anxiety Disorders.
• Vortioxetine in Patients With Depression Coexisting With General Anxiety Disorder (GAD)
• Distraction and Nitrous Oxide for Venous Puncture
• CHI-902 for Treatment of Social Anxiety Disorder
• Interactive Tablet Compared to Oral Midazolam as Premedication in Preoperative Anxiety in Children
• Trial of Naproxen Sodium for the Treatment of OCD in Children With PANDAS
• Interest of Virtual Reality in the Management of Anxiety and Pain Related to Post-cardiac Surgery Care
• A Study of Escitalopram in the Treatment of Children and Adolescents With Generalized Anxiety Disorder
• Prazosin Use in Adults With Anxiety Disorders
• Definitive Selection of Neuroimaging Biomarkers in Anxiety Disorder and Obsessive-compulsive Disorder: A Longitudinal Functional Magnetic Resonance Imaging （fMRI） Study With Paroxetine Treatment
• Randomized Trial of Adult Subjects With Generalized Anxiety Disorder
• Using Preoperative Anxiety Score to Determine the Total Dose of Butorphanol for Sedation
• Identification of Multi-modal Bio-markers for Early Diagnosis and Treatment Prediction in Schizophrenia Individuals
• A 14 Week, Randomized, Placebo-Controlled Cross-Over Study of Methylphenidate Hydrochloride Controlled Release Capsules in Adult ADHD With and Without Anxiety Disorder Comorbidity
• Efficacy and Safety Study of a IMSS Developed Phytopharmaceutical for the Treatment of Anxiety.
• Comparison of Tandospirone, Amlodipine and Their Combination in Adults With Hypertension and Anxiety
• Inhaled Oxytocin and HPA Axis Reactivity
• Cannabidiol for the Treatment of Anxiety Disorders: An 8-Week Pilot Study
• Anxiety and Depression in Epilepsy: A Pilot Treatment Study
• Treatments for Anxiety: Meditation and Escitalopram
• Bioequivalence Study of Paroxetine Tablets and Paxil® Under Fasting and Fed Conditions in Chinese Healthy Volunteers
• Coronary Angiography THerapeutic Virtual Reality
• Substance Misuse To Psychiatric Disorders for Cannabis
• The Effect of Virtual Reality Glasses on Anxiety During Surgery Under Spinal Anesthesia
• Anxiety and Depression in Epilepsy: A Treatment Study
• Lavender Oil on Preoperative Anxiety and Sedation Requirement in General Anaesthesia
• A Pilot Study of Buspirone for the Treatment of Anxiety in Youth With Autism Spectrum Disorders
• Using Preoperative Anxiety Score to Determine the Precise Dose of Butorphanol for Sedation
• Use of Clobazam for Epilepsy and Anxiety
• Effect of Attention Training or SSRIs on Symptoms and Neural Activation in Social Anxiety
• Bioequivalence Study of Paroxetine Immediate Release (IR) Tablets Manufactured in GlaxoSmithKline Tianjin (GSKT) and Mississauga Sites in Healthy Chinese Subjects
• Simplified Cognitive Behavioral Therapy for Generalized Anxiety Disorder and Depression
• Preoperative Hypnosis Versus Premedication in Gynecological Surgery
• Chinese Herb for the Treatment of Depression and Anxiety Disorders
• Specifying and Treating Anxiety in Autism Research
• Psycho-biological Substrates of Therapeutic Benefit of Thermal Cure on Generalized Anxiety Disorders
• Effects of Virtual Reality on Pre-Operative Anxiety and Induction of Anesthesia in Children and Adolescents
• Is Initial Response to Low Dose Risperidone Predictive for Outcome in Anxiety?
• Comparative Evaluation of Three Anxiety Control Protocols in Third Molar Extraction
• LSD Treatment in Persons Suffering From Anxiety Symptoms in Severe Somatic Diseases or in Psychiatric Anxiety Disorders
• Escitalopram in the Treatment of Adolescents With Major Depressive Disorder or Anxiety Disorders
• Anxiety-mediated Impairments in Large Elastic Artery Function and the Autonomic Nervous System
• Effects of Aromatherapy on Anxiety in Invasive Radiologic Procedure
• Multiple Dose Effect of Oxytocin on Males With High or Low Trait Anxiety
• A Study of the Efficacy of Botox in the Treatment of Social Anxiety Disorder
• Randomized Clinical Trial of a Mindfulness Based Intervention in Generalized Anxiety Disorder
• Intranasal Ketamine for Anxiolysis in Pediatric Emergency Department Patients
• Effects of SRX246 on an Experimental Model of Fear and Anxiety in Humans
• Tenoten® in the Treatment of Somatoform, Stress-related and Other Neurotic Disorders
• Effect of Transcranial Magnetic Stimulation to the Frontoparietal Attention Network on Anxiety Potentiated Startle
• Acute Anxiolytic Effects of Riluzole on Subjects With Social Anxiety Disorder
• CAMH - McMaster Collaborative Care Initiative For Mental Health Risk Factors In Dementia
• Exploring the Impact of Perioperative Galacto-Oligosaccharides (GOS) on Stress, Anxiety and Cognition
• Decreasing REcurrent Pain and Anxiety in Medical Procedures With a Pediatric Population: Trial
• D-Cycloserine and Virtual Reality Exposure Therapy
• Evaluation of a Psychotherapeutic Intervention Model in Nursing
• Brief Intervention to Reduce Fear of Public Speaking
• Effects of SRX246 on an Experimental Model of Fear and Anxiety in Humans
• Sudarshan Kriya Yoga and Cardiac Autonomic Control in Patients With Anxiety-Depression Disorders
• Neurofunctional Predictors of Escitalopram Treatment Response in Adolescents With Anxiety
• Inositol for Comorbid Anxiety in Children and Adolescents With Bipolar Disorder
• Brief Intervention to Reduce Fear of Public Speaking
• Oxytocin Suppresses Substance Use Disorders Associated With Chronic Stress
• Feasibility Study of PH94B Nasal Spray for Acute Treatment of Social Anxiety Disorder (SAD)
• Intranasal Midazolam for Treatment of Anxiety in Children Undergoing Suturing in the Pediatric Emergency Department
• Neural Basis of Meal Related Interoceptive Dysfunction in Anorexia Nervosa
• Integrating Psychotropic Medication Into the Care of People With Mental Disorders in a Prayer Camp in Ghana
• Ketamine Infusion for Adolescent Depression and Anxiety
• Efficacy of Nepeta Menthoides Extract on Anxiety of Patients With Depression: a Double-blind Randomized Controlled Clinical Trial
• Sublingual Cannabidiol for Anxiety
• Exercise and Pharmacotherapy for Anxiety in Cardiac Patients
• Initial Severity and Antidepressant Efficacy for Anxiety Disorders: an Individual Patient Data Meta-analysis
• Effect of Lactobacillus Plantarum 299v Supplementation on Major Depression Treatment
• A Safety and Efficacy Study of JNJ-42165279 in Participants With Social Anxiety Disorder
• MDMA-Assisted Psychotherapy for Anxiety Associated With a Life-Threatening Illness
• Pharmacovigilance in Gerontopsychiatric Patients
• Disentangling Anxiety Sensitivity and Anxiety-induced Physiological Stress Response
• Anxiety in Parkinson's: Use of Quantitative Methods to Guide Rational Treatment
• Effects of Fast Acting Testosterone Nasal Spray on Anxiety
• Trial of Sertraline Versus Cognitive Behaviour Therapy for Generalised Anxiety
• Music Therapy in Obsessive Compulsive Disorder
• POC Study in Partially Responsive Generalized Anxiety Disorder
• EDG004 Treatment of Adult Patients With Generalized Anxiety Disorder (GAD)
• Vortioxetine Versus Placebo in Major Depressive Disorder Comorbid With Social Anxiety Disorder
• FASTMAS (Fast-Fail Trials in Mood and Anxiety Spectrum Disorders) Kappa Opioid Receptor Phase 1 Study
• Fast-Fail Trials in Mood and Anxiety Spectrum Disorders; Kappa Opioid Receptor Phase 2a
• Premedication by Midazolam for Emergency Surgery
• Minocycline Hydrochloride in Reducing Chemotherapy Induced Depression and Anxiety in Patients With Stage I-III Breast Cancer
• Treatment of Pediatric Anxiety Disorders by Predicting Treatment Response Through Biocellular Markers and Sleep
• Efficacy Study of Abdominal Massage Therapy to Treat Generalized Anxiety Disorder of Deficiency of Both Heart and Spleen Type
• Cognitive vs. Emotional Psychopharmacological Manipulations of Fear vs. Anxiety
• Medication Enhanced Rapid Therapy
• A Comparison of Midazolam and Zolpidem as Oral Premedication in Children
• Ketamine Infusion for Social Anxiety Disorder
• Dose Timing of D-Cycloserine to Augment CBT for Social Anxiety Disorder
• Probiotics and the Microbiome: Clinical Intervention Trial for Anxiety and Depression
• Comparison of Effect of Nitrous Oxide-Oxygen Conscious Sedation and Cognitive-behavioral Therapy on Children's Anxiety in Dentistry
• Efficacy of Exposure and Response Prevention(ERP) and SSRIs in Chinese OCD Patients
• Brexpiprazole (OPC-34712) as an Adjunctive Treatment in Adults With Major Depressive Disorder and Anxiety Symptoms
• Phase 2 Pilot Safety Study of MDMA-assisted Therapy for Social Anxiety in Autistic Adults
• Smoking Cessation for Depression and Anxiety Treatment
• Vilazodone for Separation Anxiety Disorder
• Sequencing CBT for Child Anxiety: CBT Plus Sertraline Versus Switch to Sertraline
• Efficacy of SNRI Treatment on Prefrontality in Patients With GAD and Other Comorbities
• Efficacy of Extended-release Quetiapine (Seroquel XR) as Adjunctive Therapy to Cognitive Behavioral Therapy in the Treat
• Anxiety Control by Erythrina Mulungu
• Treatment of Anxiety and Anorexia Nervosa in Adolescents
• Reduced Nicotine Cigarettes in Smokers With Mood and Anxiety Disorders
• Negative Valence Brain Targets and Predictors of Anxiety and Depression Treatment
• Treating Emotional Disorders in Primary Care With Psychological Techniques
• Generalization of Extinction Learning
• Pilot Study of Cognitive Behavioral Therapy for Anxiety and Bipolar I Disorder
• A Study of Methods to Reduce Anxiety in Preoperative Elective Surgical Patients
• Lisdexamfetamine Dimesylate in the Treatment of Adult ADHD With Anxiety Disorder Comorbidity
• Effect of Oxytocin Nasal Sprays on Social Behavior in Social Anxiety Disorder
• Bioequivalence Trial of Alprazolam 0.25 mg Tablets
• An Open-Label Trial of Buspirone for the Treatment of Anxiety in Youth With Autism Spectrum Disorders
• Safety, Efficacy and Tolerability of Vilazodone in (GAD) Generalized Anxiety Disorder
• Evaluation of Oral Midazolam in First-trimester Surgical Abortions
• The Effects of JNJ-42165279 on the Neural Basis of Anxiety Disorders in Healthy Male Volunteers
• Smoking Termination / Anxiety Reduction Treatment (ST/ART)
• Efficacy of Clonidine and Propranolol in Dentistry (AAA)
• Safety, Efficacy and Tolerability of Vilazodone in Patients With Generalized Anxiety Disorder
• Baclofen for Treating Anxiety and Alcoholism
• Bioequivalence Study of Escitalopram Tablets 10 mg
• Bioequivalence Trial of Alprazolam 2 mg Tablets
• Bioequivalence Trial of Alprazolam 0.5 mg Tablets
• Study of Vilazodone to Treat Social Anxiety Disorder
• Sensitivity of Short and Long Allele Carriers of the 5-HTTLPR to Environmental Threat Post Hydrocortisone Administration
• Oral Ketamine in the Treatment of Depression and Anxiety in Patients With Cancer
• Clinical Benefits of Seroquel XR in Anxiety Disorder
• The Effect of Virtual Reality Glasses on Pain and Anxiety
• Pilot Study of Pharmaceutical and Behavioral Interventions to Treat Anxiety Disorders
• Safety, Efficacy and Tolerability of Vilazodone in Generalized Anxiety Disorder
• Tandospirone Citrate in the Treatment of Patients With Generalized Anxiety Disorder
• WEUKBRE5559: IMI PROTECT: Benzodiazepines & Fracture
• Reassessment of Premedication in Surgery
• Effects of Buspar on Depressive Symptom Improvement and Neuroprotection in Patients With Anxiety Disorder
• Escitalopram in Anxiety Associated Chronic Obstructive Pulmonary Disease (COPD) Exacerbations
• Pregablin for Anxiety-comorbidity in Patients With Schizophrenia
• Buspirone Therapy for Localized Epilepsy
• Pharmacokinetics and Tolerability of Vortioxetine (Lu AA21004) in Child and Adolescent Patients With Depressive or Anxiety Disorder
• Multimodal Assessment of Neurobiological Markers for Psychiatric Disorders
• SPD503 in Subjects Aged 6-17 Years With Generalized Anxiety Disorder (GAD), Separation Anxiety Disorder (SAD), or Social Phobia (SoP)
• Study of Donepezil in Female Breast Cancer Survivors With Cognitive Dysfunction
• The Effect of Medical Clowns and Topical Anesthetic Cream on Pain and Anxiety in Children Undergoing Allergy Skin Tests
• Emotional Processing in Healthy Volunteers in the Presence of an Investigational Anxiolytic
• Vibrating, Cold Device for Pediatric Intravenous (IV) Cannulation Pain Relief
• Special Drug Use Investigation for PAXIL (Paroxetine) Social Anxiety Disorder (Long-term)
• Does Hydroxyzine Decrease Anxiety in Underweight Patients Diagnosed With an Eating Disorder
• The Effect of Sihogayonggolmoryeo-tang on the Anxiety of Hwa-byung
• Antiglucocorticoid Therapy for Cognitive Impairment in Late-life Anxiety Disorders
• 12-Week Study of Pristiq (Desvenlafaxine) Social Anxiety Disorder
• A Clinical Trial to Study the Effects of Sensoril® for Patients With Generalized Anxiety Disorder
• Does Pregabalin Improve Symptoms of Anxiety in Patients With Epilepsy? A Comparison With Sertraline
• Cipralex® for Anxiety Disorders in Adolescents
• The Comparative Clinical Study of Gamisoyosan on Anxiety of Generalized Anxiety Disorder According to Dosage Form
• Intravenous Immunoglobulin for PANDAS
• Pharmacokinetics Of Alprazolam Sublingual Tablet Versus Conventional Tablet
• Open-Label Pilot Study to Examine the Value of Substituting Quetiapine for Benzodiazepines
• Corticotropin-Releasing Hormone Receptor 1 (CRH1) Antagonism in Anxious Alcoholics^
• A Study in Pediatric Participants With Generalized Anxiety Disorder
• Adjunctive Quetiapine in the Treatment of Refractory Social Anxiety Disorder in Adults
• Intranasal PH94B for Management of the Symptoms of Generalized Social Phobia
• Therapeutic Effect of an Herbal Medicine on Anxiety
• Ziprasidone in Bipolar Disorder With Comorbid Lifetime Panic or Generalized Anxiety Disorder(GAD)
• Brain Markers of Anxiety Disorders and SSRI/CBT Treatment in Children and Adolescents
• A Study of Duloxetine in Elderly Generalized Anxiety Disorder
• Long Term Chamomile Therapy for Anxiety
• Generalized Anxiety and Seroquel
• First Study in Humans With GSK424887
• First Study in Humans With GSK206136
• First Time in Human Study
• Oxytocin Add-on Study for Stable Anxiety Patients
• Psilocybin-Assisted Psychotherapy for Anxiety in People With Stage IV Melanoma
• Effects of 3 Months of Selective Serotonin Reuptake Inhibitor (SSRI)-Treatment on Metabolism and Hypothalamic-pituitary-adrenal (HPA)-Axis in Young Men Born With Low Birth Weight
• Anxiety and Recurrent Abdominal Pain in Children
• An Open Label Trial of Duloxetine in the Treatment of Irritable Bowel Syndrome and Comorbid Generalized Anxiety Disorder
• Mirtazapine Reduces ICD Shocks in ICD Patients With Depression and Anxiety
• Yohimbine to Enhance Cognitive Behavioral Therapy (CBT) for Social Anxiety
• Psilocybin Cancer Anxiety Study
• Cardiovascular Biomarkers and Quetiapine in Depression and Anxiety Patients
• Efficacy and Tolerability Study to Treat Mild and Moderate Anxiety
• Efficacy and Feasibility of a Personalized Treatment for Depression With Co-Occurring Anxiety
• Cranial Electro Therapy Stimulation in Reducing Perioperative Anxiety
• A 5-Week Trial Of PD 0332334 And Alprazolam Extended Release Compared To Placebo In Patients With Generalized Anxiety Disorder
• Lysergic Acid Diethylamide (LSD)-Assisted Psychotherapy in People With Illness-related Anxiety
• Gelsemium Sempervirens in Anticipatory Anxiety
• Quetiapine Augmentation for Primary Anxiety Disorder or Mood Disorders With Co-morbid Anxiety Symptoms
• Escitalopram in Patients With Generalized Anxiety Disorder
• Escitalopram in Patients With Social Anxiety Disorder
• Treatment Effects of Escitalopram (Lexapro®) on Generalized Anxiety Disorder in Patients With HIV and AIDS
• Identifying Brain and Genetic Markers of Sertraline Treatment Response in People With Social Anxiety Disorder
• Quetiapine Extended Release (XR) Treatment of Major Depressive Disorder With Comorbid Generalized Anxiety Disorder
• Fixed Dose Study of PD 0332334 and Paroxetine for the Treatment of Generalized Anxiety Disorder
• The Effects of Eszopiclone and Lexapro on Prefrontal Glutamate and GABA in Depression With Anxiety and Insomnia
• Investigation Of How PD 0332334 And Metformin Are Eliminated From The Body When They Are Administered At The Same Time
• AZD7325 Proof of Concept in Patients With Generalized Anxiety Disorder (GAD)
• Proof of Concept in Patients With Generalized Anxiety Disorder (GAD)AZD7325
• Double-Blind Placebo-Controlled Trial of Riluzole in Pediatric Bipolar Disorder
• Duloxetine for the Treatment of Generalized Anxiety Disorder
• Evaluating The Effects Of Cimetidine On The Elimination Of PD 0332334 From The Body
• Association of Passiflora Incarnata L; Crataegus Oxyacantha L and Salix Alba L. on Mild and Moderate Anxiety
• Relapse-prevention Study With Lu AA21004 (Vortioxetine) in Patients With Generalized Anxiety Disorder
• Flushing in Social Anxiety Disorder on Seroquel
• Perioperative Pregabalin Use, Rehabilitation, Pain Outcomes and Anxiety Following Hip Surgery
• Ketamine as a Rapid Treatment for Post-traumatic Stress Disorder (PTSD)
• Intranasal Administration of Neuropeptide Y in Healthy Male Volunteers
• Efficacy and Safety of Vortioxetine (Lu AA21004) for Treatment of Generalized Anxiety Disorder in Adults.
• 6-Month Open-Label Safety Study Of PD 0332334 In Elderly Patients With Generalized Anxiety Disorder (GAD)
• Treatment of Panic Disorder Among Individuals Consulting Emergency Departments for Non Cardiac Chest Pain
• A 52-Week Open-Label Safety Study of PD 0332334 in Subjects With Generalized Anxiety Disorder (GAD)
• An Efficacy and Safety Study of Vortioxetine (Lu AA21004) in Treating Generalized Anxiety Disorder
• Study of Efficacy and Safety of Vortioxetine (Lu AA21004) in Treating Generalized Anxiety Disorder
• Efficacy of Vortioxetine (Lu AA21004) in Treating Generalized Anxiety Disorder
• Disulfiram Combined With Lorazepam for Alcohol Dependence and Anxiety Disorder
• Clinical Study Assessing a New Scale to Measure Onset of Action in Generalized Anxiety Disorder
• PharmacofMRI of Anxiolytic Medications (Pregabalin)
• PharmacofMRI (Functional Magnetic Resonance Imaging) of Anxiolytic Medications (Alprazolam)
• A Study of MK0777 Gel Extrusion Module (GEM) in the Treatment of Outpatients With Generalized Anxiety Disorder (0777-019)
• A First Time in Human Study of GSK586529 in Healthy Volunteers
• Pharmacological Treatment of Generalized Anxiety Disorder in the Elderly
• Quetiapine in Co-Morbid Depressive and Anxiety Disorders
• Randomized Control Trial of a Topical Anesthetic to Evaluate Pain and Anxiety During Venipuncture
• Memantine Treatment for Obsessive-compulsive Disorder and Generalized Anxiety Disorder
• Quetiapine Extended Release (XR) in Bipolar Patients With Comorbid Generalized Anxiety Disorder (GAD)
• Anxiety in Recovering Opiate Dependence
• Drug Treatment Validation of Functional Magnetic Resonance Imaging in Generalized Anxiety Disorder
• A 10-week Study Evaluating the Efficacy and Safety of PD 0332334 for the Treatment of Generalized Anxiety Disorder (3)
• A 10-week Study Evaluating the Efficacy and Safety of PD 0332334 in Patients With Generalized Anxiety Disorder (2)
• A 10-week Study Evaluating the Efficacy and Safety of PD 0332334 in Patients With Generalized Anxiety Disorder (1)
• D-Cycloserine Enhancement of Exposure in Social Phobia
• Active Surveillance, Radical Prostatectomy, or Radiation Therapy in Treating Patients With Localized Prostate Cancer
• Safety and Efficacy Evaluation Of Pregabalin (Lyrica) With Patients With Generalized Anxiety Disorder
• Safety and Effectiveness Study of BCI-540 Versus Placebo in the Treatment of Major Depressive Disorder With Concomitant Anxiety
• Combined Treatment for Generalized Anxiety Disorder (GAD)
• Generalized Anxiety Disorder Proof of Concept Efficacy and Safety Study of SEP-225441 (Eszopiclone) In GAD Subjects
• ERP N1 as a Treatment Predictor of Generalized Anxiety Disorder
• Study to Assess the Efficacy and Safety of Levetiracetam for the Treatment of Social Anxiety Disorder (Generalized Type)
• Clowns as Treatment for Preoperative Anxiety in Children: A Randomized Controlled Trial
• An Open Label, Double-blind Discontinuation Study of Quetiapine Extended Release(XR)
• Antidepressant Treatment Plus Cognitive Behavioral Therapy for Generalized Anxiety Disorder in Older Adults
• Exploratory Study to Evaluate the Effect of SYN111 (Rufinamide) in Patients With Generalized Anxiety Disorder (GAD)
• An 8 Week Open-Label Study to Evaluate the Efficacy and Safety of Acamprosate Calcium (Campral) as Augmentation Therapy in Patients With Anxiety Symptoms Who Are Only Partial Responders to SSRI or SNRI Antidepressants
• The Use of Clonidine in Pain and Anxiety Associated With Acute Burn Injury in Children
• Quetiapine SR and Divalproex Sodium ER in the Treatment of Anxiety in Bipolar Disorder With Panic Disorder and/or GAD
• Safety and Efficacy of Oral Midazolam for Perioperative Anxiety Relief of Patients Undergoing Mohs Micrographic Surgery
• A Study To Compare The Putative Anxiolytic Effect Of 2 New Drugs In Subjects With Social Anxiety Disorder
• Study Evaluating Venlafaxine Extended-Release in Depressed and Anxious Patients
• GEM 1.5 mg b.i.d. to 4.5 mg b.i.d. Versus Lorazepam in GAD (0777-026)
• A Study of MK0777 in the Treatment of Outpatients With Generalized Anxiety Disorder (0777-020)
• A 10-Week Study Evaluating the Efficacy And Safety of PD 0332334 for the Treatment of Generalized Anxiety Disorder
• Treatment of Patients With Anxiety Disorder (0777-022)
• An Open-label Study to Investigate the Absorption, Metabolism and Excretion of Radiolabeled PD 0332334 in Six Healthy Male Volunteers
• Relative Bioavailability and Food Effect Study for GSK163090 in Healthy Male and Female Volunteers
• An Eight-Week Study to Evaluate the Efficacy and Safety of SR58611A in Elderly Patients With Generalized Anxiety Disorder
• Generalized Anxiety Disorder Adjunct Study
• Effect of D-cycloserine Plus Cognitive Behavioral Therapy on People With Social Phobia
• A Study To Investigate Effects Of GSK561679 On Brain Activation During Emotional Processing In Healthy Volunteers
• Effects of Duloxetine on Pathological Worry in Patients With Generalized Anxiety Disorder: A fMRI Study
• Flushing in Social Anxiety Disorder on Cipralex
• An Open Label Trial of Omega 3(o3mega+Joy)in the Treatment of Social Phobia
• Study of Pexacerfont (BMS-562086) in the Treatment of Outpatients With Generalized Anxiety Disorder
• Duloxetine vs Placebo in the Treatment of General Anxiety
• A Study To Compare Emotional Changes In Subjects With Social Anxiety Disorder
• St. John's Wort And Kava In The Treatment Of Major Depressive Disorder With Comorbid Anxiety
• Aripiprazole for the Treatment of Refractory Anxiety
• Study Of Safety, Blood Levels, And Brain Receptor Occupancy Of GSK163090 Using PET Imaging In Healthy Males
• To Investigate Effects GSK561679 on Part of the Body's System That Controls the Balance of Many of the Hormones.
• An Eight-week Study to Evaluate the Efficacy and Safety of Saredutant in Patients With Generalized Anxiety Disorder
• Pregabalin in the Treatment of Patients With Generalized Anxiety Disorder (GAD).
• A 10 Week Open-Label Pilot Study to Evaluate the Effectiveness and Safety of Memantine(Namenda) as Augmentation Therapy in Patients With Generalized Anxiety Disorder
• A Combination Therapy In Patients With Social Anxiety Disorder
• Treatment Of Patients With Social Anxiety Disorder
• Prevention of Relapse Study of SR58611A in Improved Patients With Generalized Anxiety Disorder
• Antidepressant Safety in Kids Study
• Efficacy of Sleep Interventions for Posttraumatic Stress Disorder (PTSD)
• A North-American Eight-week Study to Evaluate the Efficacy and Safety of Saredutant in Patients With Generalized Anxiety Disorder
• An Eight-week Study to Evaluate the Efficacy and Safety of 2 Doses of Saredutant in Patients With Generalized Anxiety Disorder
• Efficacy and Safety Study of Seroquel SR in the Treatment of Generalised Anxiety Disorder
• Ziprasidone for the Treatment of Generalized Anxiety in Patients With Bipolar Disorder
• An Eight-week Study Evaluating the Efficacy and Tolerability of Two Doses of SSR149415 in Outpatients With Generalized Anxiety Disorder
• Efficacy and Safety of Pregabalin vs Placebo for Generalized Anxiety Disorder (GAD) Symptoms in Subjects Discontinuing Benzodiazepine Treatment and Remaining 6 Weeks on Study Medication, Free From Benzodiazepine Use.
• Trial of Seroquel SR for Alcohol Dependence and Comorbid Anxiety
• Primary Care Intervention Strategy for Anxiety Disorders
• PET (Positron Emission Tomography)/Public Speaking Study With A Combination Of 2 Medications In Social Anxiety Patients
• An Eight-Week Study to Evaluate the Efficacy and Safety of SR58611A in Patients With Generalized Anxiety Disorder
• fMRI Study Comparing BOLD Activation Patterns Using GW679769 In Subjects With Social Anxiety Disorder
• Acamprosate in Alcoholics With Comorbid Anxiety or Depression
• Safety & Efficacy Study of Quetiapine Fumarate (SEROQUEL®) vs. Placebo & Active Control in Generalized Anxiety Disorder
• Safety & Efficacy Study of Quetiapine Fumarate (SEROQUEL®) vs. Placebo in Generalized Anxiety Disorder
• Efficacy and Safety Study of Seroquel SR in the Treatment of Generalized Anxiety Disorder
• Social Anxiety Disorder Study Of Paroxetine
• Safety and Efficacy Maintenance Study of Quetiapine SR to Treat GAD Patients.
• Efficacy of Quetiapine in Generalised Social Anxiety Disorder
• Effects of Psilocybin in Advanced-Stage Cancer Patients With Anxiety
• Safety and Efficacy Study of AV608 in Subjects With Social Anxiety Disorder
• Improving Treatment Outcomes in Pharmacotherapy of Generalized Social Anxiety Disorder
• Study of Risperidone Monotherapy in Ambulatory Bipolar Disorder With Concurrent Moderately Severe Anxiety and Lifetime Panic or Generalized Anxiety Disorder
• A Study Of A New Medicine (GW679769) For The Treatment Of Social Anxiety Disorder
• An Eight-Week Study to Evaluate the Efficacy and Safety of SR58611A in Patients With Generalized Anxiety Disorder
• Trial to Compare Time to Response in the Symptoms of Anxiety to Concomitant Treatment With Niravam™ and an SSRI or SNRI to Treatment With an SSRI or SNRI Alone in Subjects With Generalized Anxiety Disorder or Panic Disorder
• Efficacy and Tolerability of Atomoxetine (Strattera) in Adult Patients With Generalized Social Anxiety Disorder
• Efficacy and Safety of SR58611A in Patients With a Generalized Anxiety Disorder
• MDMA-assisted Therapy in People With Anxiety Related to Advanced Stage Cancer
• Psychosocial and Medication Treatment for Anxiety in Alcoholism
• A Study To Evaluate PRX-00023 In Patients With Generalized Anxiety Disorder (GAD)
• Paroxetine for Comorbid Social Anxiety Disorder and Alcoholism
• Trial of Pregabalin, Alprazolam, and Placebo in Subjects With Anxiety Prior to Dental Procedure
• Study Evaluating Venlafaxine ER in Children and Adolescents With Social Anxiety Disorder
• A 10-Week Study for Efficacy and Safety Study of Gabitril in the Treatment of Adults With Generalized Anxiety Disorder
• A 10-Week Efficacy and Safety Study for of Gabitril in the Treatment of Adults With Generalized Anxiety Disorder
• A 10-Week Efficacy and Safety Study of Gabitril in the Treatment of Adults With Generalized Anxiety Disorder
• Safety and Efficacy of Eszopiclone in Patients With Generalized Anxiety Disorder
• Evaluate the Safety of GABITRIL in Adults With Generalized Anxiety Disorder
• Nefazodone in the Treatment of Social Phobia
• A Double Blind, Randomized Placebo Controlled Study of the Efficacy, Safety and of Quetiapine Fumarate (Seroquel®) as Potentiation SSRI's, and SNRI's Treatment in Major Depression With Anxiety
• Cognitive-Behavioral Therapy and Escitalopram for Generalized Anxiety Disorder(GAD)
• Quetiapine in Social Anxiety Disorder
• Geodon for the Treatment of Refractory Social Anxiety Disorder
• Study to Evaluate the Safety and Efficacy of GABITRIL Treatment in Adults With Generalized Anxiety Disorder.
• Study To Evaluate The Effects Of Gabitril™ In Patients With Social Anxiety Disorder
• Treatment of Citalopram for Anxiety Disorders Following a Traumatic Brain Injury
• Abilify Therapy for Reducing Comorbid Substance Abuse
• Comparison of LY686017 With a Marketed Drug in the Treatment of Social Anxiety Disorder
• Placebo-Controlled Study of Atomoxetine Hydrochloride in the Treatment of Adults With ADHD and Comorbid Social Anxiety Disorder
• Effectiveness of Long-Term Versus Short-Term Treatment of Generalized Anxiety Disorder With Venlafaxine XR
• Sertraline in Generalized Social Phobia With Co-Occurring Anxiety and Mood Disorders
• Aripiprazole for the Treatment of Schizophrenia With Co-Morbid Social Anxiety
• A GameBoy as a Distraction Before Surgery in Children
• Switching From an SSRI to Tiagabine(GABITRIL) in Order to Alleviate SSRI Induced Sexual Dysfunction
• A Study of Risperidone Monotherapy in Bipolar Anxiety
• Treating Climacteric Symptoms With a Complex Homeopathic Remedy
• Comparison of Pregabalin Versus Venlafaxine XR and Placebo in the Treatment of Generalized Anxiety Disorder
• Determine Long-Term Safety and Tolerability of Pregabalin in Patients With Anxiety Disorders.
• Effectiveness of Escitalopram in the Treatment of Body Dysmorphic Disorder
• Levetiracetam for the Treatment of Alcohol Dependence and Anxiety
• A Multicenter, Open-Label, Randomized Crossover Trial to Assess Subject Preference for Alprazolam Orally Disintegrating Tablets Compared to Conventional Alprazolam Tablets in Subjects With Anxiety
• Study Of Generalized Anxiety Disorder
• Duloxetine Compared With Placebo in the Prevention of Relapse in Generalized Anxiety Disorder
• A Comparison of Duloxetine Hydrochloride, Marketed Comparator, and Placebo in the Treatment of Generalized Anxiety Disorder
• A Comparison of Duloxetine Hydrochloride, Marketed Comparator, and Placebo in the Treatment of Generalized Anxiety Disorder
• Duloxetine Compared With Placebo in Patients With Generalized Anxiety Disorder
• St. John's Wort for the Treatment of Generalized Social Anxiety Disorder (GSAD)
• SSRI Administration to Reduce Acute Stress Disorder Symptoms and Prevent Depression and PTSD in Physical Trauma Victims
• Duloxetine for Social Anxiety Disorder: Prediction of Long Term Outcome
• Combination of Paroxetine CR and Quetiapine for the Treatment of Refractory Generalized Anxiety Disorder
• Efficacy, Safety and Tolerability of XBD173 in Patients With Generalized Anxiety Disorder
• A Long-Term Study Continuing on From Study 04-001-01 of an Experimental Medication in Adults With Anxiety Disorder
• Drug Therapy for Generalized Anxiety Disorder Among the Elderly
• Experimental Medication For the Treatment of Generalized Anxiety Disorder
• Study Comparing Risperidone vs Placebo as add-on Therapy in Patients With Generalized Anxiety Disorder Who Are Sub-optimally Responding to Standard Therapy.
• Kava Kava for the Treatment of Generalized Anxiety Disorder (GAD)
• Adding Cognitive Behavioral Therapy to Drug Treatment for Social Anxiety Disorder
• Duloxetine Compassionate Use in Patients Who Have Completed a Previous Neuroscience Duloxetine Clinical Trial
• Child and Adolescent Anxiety Disorders (CAMS)
• Lorazepam-Induced Toxicity in the Aged
• Gabapentin For the Control of Hot Flashes in Women With Breast Cancer
• Clinical Trial of Fluoxetine in Anxiety and Depression in Children, and Associated Brain Changes
• Treatment of Youth With ADHD and Anxiety
• Combination Chemotherapy Plus Fluoxetine in Treating Patients With Advanced or Recurrent Non-Small Cell Lung Cancer
• Phase II Double-Blind, Placebo-Controlled Study of the Reinforcing Effects of Alprazolam in Patients With Anxiety
• New Drugs in the Treatment of Mood Disorders
• Treatment for Anxiety in Children
• Fluoxetine for Anxious Children
• Cognitive and Drug Therapy for Drug-Resistant Depression